Physician profile
Cuong M Vu
NPI 1649455775
$2,920.16
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $864 · 2021: $583 · 2022: $549 · 2023: $324 · 2024: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,445.86 | 2019-2024 | Proclaim, Eterna, Octrode |
| Vgi Medical, LLC | $444.80 | 2020 | |
| Nalu Medical, INC. | $210.96 | 2021-2022 | |
| Abbvie INC. | $203.21 | 2022-2024 | Botox, Qulipta |
| Boston Scientific Corporation | $165.83 | 2019-2021 | |
| Vertos Medical, INC. | $104.10 | 2024 | Mild Device Kit |
| Grt US Holding, INC. | $55.61 | 2021-2022 | |
| Allergan, INC. | $44.17 | 2019-2021 | |
| Averitas Pharma INC. | $36.91 | 2023 | Qutenza |
| Pacira Pharmaceuticals Incorporated | $34.44 | 2023 | Iovera |
| Scilex Pharmaceuticals INC. | $32.32 | 2019-2022 | |
| Pfizer INC. | $31.14 | 2024 | |
| Collegium Pharmaceutical, INC. | $28.35 | 2019-2021 | |
| Merz Pharmaceuticals, LLC | $27.75 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $22.37 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $17.16 | 2022 | |
| Biodelivery Sciences International, INC. | $15.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cuong Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.